Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Venous Thrombosis IV: Nursing Management

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

Pulmonary Embolism III: Nursing Management

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Coagulation and platelet biology at the intersection of health and disease: illustrated capsules of the 11th Symposium on Hemostasis at the University of North Carolina.

Research and practice in thrombosis and haemostasis·2024

Same author

Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers.

Research and practice in thrombosis and haemostasis·2021

Same author

Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score.

Thrombosis and haemostasis·2018

Same author

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.

Blood·2018

Same author

Is food intolerance a factor underlying chronic immune thrombocytopenia (ITP)?

British journal of haematology·2017

Same author

Novel targets for anticoagulants lacking bleeding risk.

Current opinion in hematology·2017

Search research articles

Related Experiment Video

Updated: May 31, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Using the laboratory to predict recurrent venous thrombosis.

Trevor Baglin¹

¹Department of Haematology, Addenbrooke's NHS Trust, Cambridge, UK. trevor.baglin@addenbrookes.nhs.uk

International Journal of Laboratory Hematology

|June 23, 2011

Summary

First-generation thrombophilia testing identifies defects linked to initial venous thrombosis but not recurrence risk. Second-generation testing, assessing global coagulation, shows promise for predicting recurrent venous thromboembolism risk.

Related Experiment Videos

Last Updated: May 31, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Area of Science:

Genetics and Genomics
Hematology
Biochemistry

Background:

Heritable thrombophilic defects influence venous thromboembolism (VTE) risk.
Gene-environment interactions are crucial in VTE development.
Limited first-generation thrombophilia testing poorly predicts recurrent VTE.

Purpose of the Study:

To evaluate the predictive value of thrombophilia testing for recurrent venous thrombosis.
To explore advanced testing strategies for improved risk assessment.
To bridge the gap between identified thrombotic defects and actual recurrence risk.

Main Methods:

Analysis of first-generation thrombophilia testing limitations.
Investigation of gene-environment interactions in VTE.
Evaluation of second-generation thrombophilia testing (global coagulation assays, thrombin generation potential).
Exploration of genome-wide mutation and SNP detection.

Main Results:

First-generation testing shows limited utility in predicting recurrent VTE.
Observed intermediate phenotypes from limited testing do not correlate well with recurrence risk.
Emerging evidence supports the predictive value of second-generation testing for recurrent VTE.

Conclusions:

Limited dichotomous thrombophilia testing is insufficient for predicting recurrent VTE.
Second-generation thrombophilia testing offers improved clinical predictive value for recurrence.
Integrating global coagulation tests and genetic analysis can enhance VTE risk quantification and personalize patient care.